Even if VEGF was primarily studied here to assess HIF1α transcriptional activity, our results highlight an interest in further investigating the HIF1α–VEGF axis in FSHD, for which evidence of vascular troubles was reported. The gene discussed is HIF1A; the disease is facioscapulohumeral muscular dystrophy.